Eugene Youkilis serves as Executive at Immune Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Eugene Youkilis has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 23, 2014 involved transacting 33,125 shares valued at $0.
Eugene Youkilis currently holds 1,121,808 shares of Immune Therapeutics, Inc. (IMUN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eugene Youkilis has been a net neutral trader of IMUN stock. They have purchased $0 and sold $0 worth of shares.
Eugene Youkilis's most recent insider trade was on Dec 23, 2014, when they sold 33,125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.25 |
| Discretionary |